Regulation of mammalian nucleotide metabolism and biosynthesis

Nucleic Acids Research

Volumn 43, Issue 4, 2015, Pages 2466-2485

  Lane, Andrew N ^a   Fan, Teresa W M ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; NUCLEOTIDE; RNA;

ANIMAL; BIOSYNTHESIS; CELL CYCLE; GENETICS; HUMAN; METABOLISM; MOUSE;

ANIMALS; CELL CYCLE; DNA; HUMANS; METABOLIC NETWORKS AND PATHWAYS; MICE; NUCLEOTIDES; RNA;

EID: 84941072886     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkv047     Document Type: Review

References (229)

1. Hangauer, M.J., Vaughn, I.Q., McManus, M.T. (2013) Pervasive transcription of the human genome produces thousands of previously unidentified long intergenic noncoding RNAs. PLoS Genet., 9, e1003569.
2. Djebali, S., Davis, C.A., Merkel, A., Dobin, A., Lassmann, T., Mortazavi, A., Tanzer, A., Lagarde, J., Lin, W., Schlesinger, F. et al. (2012) Landscape of transcription in human cells. Nature, 489, 101-108.
3. Graur, D., Zheng, Y.C., Price, N., Azevedo, R.B.R., Zufall, R.A., Elhaik, E. (2013) On the immortality of television sets: "function" in the human genome according to the evolution-free gospel of ENCODE. Genome Biol. Evol., 5, 578-590.
4. Dunham, I., Kundaje, A., Aldred, S.F., Collins, P.J., Davis, C., Doyle, F., Epstein, C.B., Frietze, S., Harrow, J., Kaul, R. et al. (2012) An integrated encyclopedia of DNA elements in the human genome. Nature, 489, 57-74.
5. Sigoillot, F.D., Berkowski, J.A., Sigoillot, S.M., Kotsis, D.H., Guy, H.I. (2003) Cell cycle-dependent regulation of pyrimidine biosynthesis. J. Biol. Chem., 278, 3403-3409.
6. Quéméneur, L., Gerland, L.-M., Flacher, M., Ffrench, M., Revillard, J.-P., Genestier, L. (2003) Differential control of cell cycle, proliferation, and survival of primary T lymphocytes by purine and pyrimidine nucleotides. J. Immunol., 170, 4986-4995.
7. Fridman, A., Saha, A., Chan, A., Casteel, D.E., Pilz, R.B., Boss, G.R. (2013) Cell cycle regulation of purine synthesis by phosphoribosyl pyrophosphate and inorganic phosphate. Biochem. J., 454, 91-99.
8. Wahl, A.F., Geis, A.M., Spain, B.H., Wong, S.W., Korn, D., Wang, T.S.F. (1988) Gene-expression of human DNA polymerase-alpha during cell-proliferation and the cell-cycle. Mol. Cell. Biol., 8, 5016-5025.
9. Wang, W., Fridman, A., Blackledge, W., Connelly, S., Wilson, I.A., Pilz, R.B., Boss, G.R. (2009) The phosphatidylinositol 3-kinase/akt cassette regulates purine nucleotide synthesis. J. Biol. Chem., 284, 3521-3528.
10. Laliberte, J., Yee, A., Xiong, Y., Mitchell, B.S. (1998) Effects of guanine nucleotide depletion on cell cycle progression in human T lymphocytes. Blood, 91, 2896-2904.
11. Evans, D.R., Guy, H.I. (2004) Mammalian pyrimidine biosynthesis: fresh insights into an ancient pathway. J. Biol. Chem., 279, 33035-33038.
12. Boren, J., Cascante, M., Marin, S., Comin-Anduix, B., Centelles, J.J., Lim, S., Bassilian, S., Ahmed, S., Lee, W.N.P., Boros, L.G. (2001) Gleevec (ST1571) influences metabolic enzyme activities and glucose carbon flow toward nucleic acid and fatty acid synthesis in myeloid tumor cells. J. Biol. Chem., 276, 37747-37753.
13. Kondo, M., Yamaoka, T., Honda, S., Miwa, Y., Katashima, R., Moritani, M., Yoshimoto, K., Hayashi, Y., Itakura, M. (2000) The rate of cell growth is regulated by purine biosynthesis via ATP production and G(1) to S phase transition. J. Biochem., 128, 57-64.
14. Macallan, D.C., Fullerton, C.A., Neese, R.A., Haddock, K., Park, S.S., Hellerstein, M.K. (1998) Measurement of cell proliferation by labeling of DNA with stable isotope-labeled glucose: studies in vitro, in animals, and in humans. Proc. Natl. Acad. Sci. U.S.A., 95, 708-713.
15. Liu, Y.-C., Li, F., Handler, J., Huang, C.R.L., Xiang, Y., Neretti, N., Sedivy, J.M., Zeller, K.I., Dang, C.V. (2008) Global regulation of nucleotide biosynthetic genes by c-Myc. PLoS One, 3, e2722.
16. Wang, H., Mannava, S., Grachtchouk, V., Zhuang, D., Soengas, M.S., Gudkov, A.V., Prochownik, E.V., Nikiforov, M.A. (2008) c-Myc depletion inhibits proliferation of human tumor cells at various stages of the cell cycle. Oncogene, 27, 1905-1915.
17. Zeller, K., Zhao, X., Lee, C., Chiu, KP, Yao, F., Yustein, J.T., Ooi, H.S., Orlov, Y.L., Shahab, A., Yong, H.C. et al. (2006) Global mapping of c-Myc binding sites and target gene networks in human B cells. Proc. Natl. Acad. Sci. U.S.A., 103, 7834-17839.
18. Hu, S., Balakrishnan, A., Bok, R.A., Anderton, B., Larson, P.E.Z., Nelson, S.J., Kurhanewicz, J., Vigneron, D.B., Goga, A. (2011) (13)C-pyruvate imaging reveals alterations in glycolysis that precede c-Myc-induced tumor formation and regression. Cell Metab., 14, 131-142.
19. Yuneva, M.O., Fan, T.W.-M., Allen, T.D., Higashi, R.M., Ferraris, D.V., Tsukamoto, T., Matés, J.M., Alonso, F.J., Wang, C., Seo, Y. et al. (2012) The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type. Cell Metab., 15, 157-170.
20. Nie, Z., Hu, G., Wei, G., Cui, K., Yamane, A., Resch, W., Wang, R., Green, D.R., Tessarollo, L., Casellas, R. et al. (2012) c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells. Cell, 151, 68-79.
21. Lin, C.Y., Loven, J., Rahl, P.B., Paranal, R.M., Burge, C.B., Bradner, J.E., Lee, T.I., Young, R.A. (2012) Transcriptional amplification in tumor cells with elevated c-Myc. Cell, 151, 56-67.
22. Tong, X.M., Zhao, F.P., Thompson, C.B. (2009) The molecular determinants of de novo nucleotide biosynthesis in cancer cells. Curr. Opin. Genet. Dev., 19, 32-37.
23. Bester, A.C., Roniger, M., Oren, Y.S., Im, M.M., Sarni, D., Chaoat, M., Bensimon, A., Zamir, G., Shewach, D.S., Kerem, B. (2011) Nucleotide deficiency promotes genomic instability in early stages of cancer development. Cell, 145, 435-446.
24. Mannava, S., Grachtchouk, V., Wheeler, L.J., Im, M., Zhuang, D.Z., Slavina, E.G., Mathews, C.K., Shewach, D.S., Nikiforov, M.A. (2008) Direct role of nucleotide metabolism in C-MYC-dependent proliferation of melanoma cells. Cell Cycle, 7, 2392-2400.
25. Le, A., Lane, A.N., Hamaker, M., Bose, S., Barbi, J., Tsukamoto, T., Rojas, C.J., Slusher, B.S., Zhang, H., Zimmerman, L.J. et al. (2012) Myc induction of hypoxic glutamine metabolism and a glucose-independent TCA cycle in human B lymphocytes. Cell Metab., 15, 110-121.
26. Dang, C.V., Le, A., Gao, P. (2009) MYC-induced cancer cell energy metabolism and therapeutic opportunities. Clin. Cancer Res., 15, 6479-6483.
27. Cunningham, J.T., Moreno, M.V., Lodi, A., Ronen, S.M., Ruggero, D. (2014) Protein and nucleotide biosynthesis are coupled by a single rate-limiting enzyme, PRPS2, to drive cancer. Cell, 157, 1088-1103.
28. Kim, J., Lee, J.-H., Iyer, V.R. (2008) Global identification of Myc target genes reveals its direct role in mitochondrial biogenesis and its E-box usage in vivo. PLoS One, 3, e1798.
29. Gao, P., Tchernyshyov, I., Chang, T.C., Lee, Y.S., Kita, K., Ochi, T., Zeller, K.I., De Marzo, A.M., Van Eyk, J.E., Mendell, J.T. et al. (2009) c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature, 458, 762-765.
30. O'Donnell, K.A., Wentzel, E.A., Zeller, K.I., Dang, C.V., Mendell, J.T. (2005) c-Myc-regulated microRNAs modulate E2F1 expression. Nature, 435, 839-843.
31. Han, H., Sun, D., Li, W., Shen, H., Zhu, Y., Li, C., Chen, Y., Lu, L., Li, W., Zhang, J. et al. (2013) A c-Myc-microRNA functional feedback loop affects hepatocarcinogenesis. Hepatology, 57, 2378-2389.
32. Johnston, A., Gudjonsson, J.E., Sigmundsdottir, H., Ludviksson, B., Valdimarsson, H. (2005) The anti-inflammatory action of methotrexate is not mediated by lymphocyte apoptosis, but by the suppression of activation and adhesion molecules. Clin. Immunol., 114, 154-163.
33. Goodsell, D.S. (1999) The molecular perspective: methotrexate. Oncologist, 4, 340-341.
34. Plunkett, W., Huang, P., Xu, Y., Heinemann, V., Grunewald, R., Gandhi, V. (1995) Gemcitabine: metabolism, mechanisms of action, and self-potentiation. Semin. Oncol., 22, 3-10.
35. Evans, W. (2004) Pharmacogenetics of thiopurine S-methyltransferase and thiopurine therapy. Ther. Drug Monit., 26, 186-191.
36. Longley, D., Harkin, D., Johnston, P. (2003) 5-fluorouracil: mechanisms of action and clinical strategies. Nat. Rev. Cancer, 3, 330-338.
37. Jordheim, L.P., Durantel, D., Zoulim, F., Charles Dumontet, C. (2013) Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases. Nat. Rev. Drug Discov., 12, 447-464.
38. Li, F., Maag, H., Alfredson, T. (2008) Prodrugs of nucleoside analogues for improved oral absorption and tissue targeting. J. Pharm. Sci., 97, 1109-1134.
39. Schroeder, R., Waldsich, C., Wank, H. (2000) Modulation of RNA function by aminoglycoside antibiotics. EMBO J., 19, 1-9.
40. Shaw, R.J., Cantley, L.C. (2012) Decoding key nodes in the metabolism of cancer cells: sugar & spice and all things nice. F1000 Biol. Rep., 4, 2.
41. Cairns, R.A., Harris, I.S., Mak, T.W. (2011) Regulation of cancer cell metabolism. Nat. Rev. Cancer, 11, 85-95.
42. Koppenol, W.H., Bounds, P.L., Dang, C.V. (2011) Otto Warburg's contributions to current concepts of cancer metabolism. Nat. Rev. Cancer, 11, 325-337.
43. Fan, T.W.-M., Lorkiewicz, P., Sellers, K., Moseley, H.N.B., Higashi, R.M., Lane, A.N. (2012) Stable isotope-resolved metabolomics and applications to drug development. Pharmacol. Ther., 133, 366-391.
44. DeBerardinis, R.J., Lum, J.J., Hatzivassiliou, G., Thompson, C.B. (2008) The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab., 7, 11-20.
45. DeBerardinis, R.J., Cheng, T. (2010) Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer. Oncogene, 29, 313-324.
46. Moreno-Sanchez, R., Rodriguez-Enriquez, S., Marin-Hernandez, A., Saavedra, E. (2007) Energy metabolism in tumor cells. FEBS J., 274, 1393-1418.
47. Vander Heiden, M.G., Cantley, L.C., Thompson, C.B. (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science, 324, 1029-1033.
48. Gillies, R.J., Gatenby, R.A. (2007) Adaptive landscapes and emergent phenotypes: why do cancers have high glycolysis J. Bioenerg. Biomembr., 39, 251-257.
49. Morrish, F., Neretti, N., Sedivy, J.M., Hockenbery, D.M. (2008) The oncogene c-Myc coordinates regulation of metabolic networks to enable rapid cell cycle entry. Cell Cycle, 7, 1054-1066.
50. Cantor, J.R., Sabatini, D.M. (2012) Cancer cell metabolism: one hallmark, many faces. Cancer Discov., 2, 1-18.
51. Dolfi, S.C., Chan, L.L.-Y., Qiu, J., Tedeschi, P.M., Bertino, J.R., Hirshfield, K.M., Oltvai, Z.N., Vazquez, A. (2013) The metabolic demands of cancer cells are coupled to their size and protein synthesis rates. Cancer Metab., 1, 20.
52. Lunt, S.Y., Vander Heiden, M.G. (2011) Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Ann. Rev. Cell Dev. Biol., 27, 441-464.
53. Schmid, D., Burmester, G.R., Tripmacher, R., Kuhnke, A., Buttgereit, F. (2000) Bioenergetics of human peripheral blood mononuclear cell metabolism in quiescent, activated, and glucocorticoid-treated states. Biosci. Rep., 20, 289-302.
54. Roberts, J.K.M., Lane, A.N., Clark, R.A., Nieman, R.H. (1985) Relationships between the rate of synthesis of ATP and the concentrations of reactants and products of ATP hydrolysis in maize root-tips, determined by P-31 nuclear magnetic-resonance. Arch. Biochem. Biophys., 240, 712-722.
55. Slater, E.C., Rosing, J., Mol, A. (1973) The phosphorylation potential generated by respiring mitochondria. Biochim. Biophys. Acta, 292, 534-553.
56. Brahimi-Horn, M.C., Pouyssegur, J. (2007) Oxygen Sensing and Hypoxia-Induced Responses, Biochemical Soceity, London, Vol. 43, pp. 165-178.
57. Buttgereit, F., Brand, M.D. (1995) A hierarchy of ATP-consuming processes in mammalian-cells. Biochem. J., 312, 163-167.
58. Schmidt, H., Siems, W., Muller, M., Dumdey, R., Rapoport, S.M. (1991) ATP-producing and consuming processes of Ehrlich mouse ascites tumor cells in proliferating and resting phases. Exp. Cell Res., 194, 122-127.
59. Prescher, J.A., Bertozzi, C.R. (2005) Chemistry in living systems. Nat. Chem. Biol., 1, 13-21.
60. Mourant, J.R., Yamada, Y.R., Carpenter, S., Dominique, L.R., Freyer, J.P. (2003) FTIR spectroscopy demonstrates biochemical differences in mammalian cell cultures at different growth stages. Biophys. J., 85, 1938-1947.
61. Greilhuber, J., Dolezel, J., Lysák, M.A., Bennett, M.D. (2005) The origin, evolution and proposed stabilization of the terms 'genome size' and 'C-value' to describe nuclear DNA contents. Ann. Bot., 95, 255-260.
62. Sharma, S., Cabana, R., Shariatmadar, S., Krishan, A. (2008) Cellular volume and marker expression in human peripheral blood apheresis stem cells. Cytometry A, 73, 160-167.
63. David, H. (1985) The hepatocyte. Development, differentiation, and ageing. Exp. Pathol. Suppl., 11, 1-148.
64. Bonifacio, G.F., Brown, T., Conn, G.L., Lane, A.N. (1997) Comparison of the electrophoretic and hydrodynamic properties of DNA and RNA oligonucleotide duplexes. Biophys. J., 73, 1532-1538.
65. Kratky, O., Leopold, H., Stabinger, H. (1973) The determination of the partial specific volume of proteins by the mechanical oscillator technique. Methods Enzymol., 27, 98-110.
66. Zucker, R.M., Cassen, B. (1969) The separation of normal human leukocytes by density and classification by size. Blood, 34, 591-600.
67. Durchschlag, H. (1989) Determination of the partial specific volume of conjugated proteins. Colloid Polymer Sci., 267, 1139-1150.
68. Alberts, B., Bray, D., Lewis, J., Raff, M., Roberts, K., Watson, J. (1994) Molecular Biology of the Cell. 3rd edn. Garland Publishing, NY.
69. Sakharkar, K.K., Chow, V.T.K., Kangueane, P. (2004) Distributions of exons and introns in the human genome. In Silico Biol., 4, 387-393.
70. Nazar, R.N. (2004) Ribosomal RNA processing and ribosome biogenesis in eukaryotes. IUBMB Life, 56, 457-465.
71. Gadian, D.G. (1995) NMR and its applications to living systems. 2nd edn. Oxford University Press, Oxford.
72. Manfredi, G., Yang, L., Gajewski, C.D., Mattiazzi, M. (2002) Measurements of ATP in mammalian cells. Methods, 26, 317-326.
73. Eguchi, Y., Shimizu, S., Tsujimoto, Y. (1997) Intracellular ATP levels determine cell death fate by apoptosis or necrosis. Cancer Res., 57, 1835-1840.
74. Zong, W.X., Thompson, C.B. (2006) Necrotic death as a cell fate. Genes Dev., 20, 1-15.
75. MacIntosh, B.R., Holash, R.J., Renaud, J.M. (2012) Skeletal muscle fatigue-regulation of excitation-contraction coupling to avoid metabolic catastrophe. J. Cell Sci., 125, 2105-2114.
76. Tatsumia, T., Shiraishia, J., Keiraa, N., Akashia, K., Manoa, A., Yamanakaa, S., Matobaa, S., Fushikib, S., Flissc, H., Nakagawaa, M. (2003) Intracellular ATP is required for mitochondrial apoptotic pathways in isolated hypoxic rat cardiac myocytes. Cardiovasc. Res., 59, 428-440.
77. Plagemann, P.G.W. (1972) Nucleotide pools in novikoff rat hepatoma cells growing in suspension culture. J. Cell Biol., 52, 131-146.
78. Traut, T.W. (1994) Physiological concentrations of purines and pyrimidines. Mol. Cell. Biochem., 140, 1-22.
79. Dolle, C., Skoge, R.H., VanLinden, M.R., Ziegler, M. (2013) NAD biosynthesis in humans-enzymes, metabolites and therapeutic aspects. Curr. Top. Med. Chem., 13, 2907-2917.
80. Tallis, M., Morra, R., Barkauskaite, E., Ahel, I. (2014) Poly(ADP-ribosyl)ation in regulation of chromatin structure and the DNA damage response. Chromosoma, 123, 79-90.
81. Reynolds, M.R., Lane, A.N., Kemp, S., Liu, Y., Hill, B., Dean, D.C., Clem, B.F. (2014) Control of glutamine metabolism by the tumor suppressor Rb. Oncogene, 33, 556-566.
82. Lin, W.Y., Arthur, G. (2007) Phospholipids are synthesized in the G2/M phase of the cell cycle. Int. J. Biochem. Cell Biol., 39, 597-605.
83. Hordern, J., Henderson, J. (1982) Comparison of purine and pyrimidine metabolism in G1 and S phases of HeLa and Chinese hamster ovary cells. Can. J. Biochem., 60, 422-433.
84. Yalcin, A., Clem, B.F., Simmons, A., Lane, A., Nelson, K., Clem, A.L., Brock, E., Siow, D., Wattenberg, B., Telang, S. et al. (2009) Nuclear targeting of 6-Phosphofructo-2-kinase (PFKFB3) increases proliferation via cyclin-dependent kinases. J. Biol. Chem., 284, 24223-24232.
85. Bao, Y., Mukai, K., Hishiki, T., Kubo, A., Ohmura, M., Sugiura, Y., Matsuura, T., Nagahata, Y., Hayakawa, N., Yamamoto, T. et al. (2013) Energy management by enhanced glycolysis in G(1)-phase in human colon cancer cells in vitro and in vivo. Mol. Cancer Res., 11, 973-985.
86. Moncada, S., Higgs, E.A., Colombo, S.L. (2012) Fulfilling the metabolic requirements for cell proliferation. Biochem. J., 446, 1-7.
87. Colombo, S.L., Palacios-Callender, M., Frakich, N., Carcamo, S., Kovacs, I., Tudzarova, S., Moncada, S. (2011) Molecular basis for the differential use of glucose and glutamine in cell proliferation as revealed by synchronized HeLa cells. Proc. Natl. Acad. Sci. U.S.A., 108, 21069-21074.
88. Young, J.D., Yao, S.Y.M., Baldwin, J.M., Cass, C.E., Baldwin, S.A. (2013) The human concentrative and equilibrative nucleoside transporter families, SLC28 and SLC29. Mol. Aspects Med., 34, 529-547.
89. Ipata, P.L., Balestri, F. (2013) The functional logic of cytosolic 5 '-nucleotidases. Curr. Med. Chem., 20, 4205-4216.
90. Austin, W.R., Armijo, A.L., Campbell, D.O., Singh, A.S., Hsieh, T., Nathanson, D., Herschman, H.R., Phelps, M.E., Witte, O.N., Czernin, J. et al. (2012) Nucleoside salvage pathway kinases regulate hematopoiesis by linking nucleotide metabolism with replication stress. J. Exp. Med., 209, 2215-2228.
91. Zhao, H., French, J., Fang, Y., Benkovic, S.J. (2013) The purinosome, a multi-protein complex involved in the de novo biosynthesis of purines in humans. Chem. Commun., 49, 4444-4452.
92. Fan, T.W.-M., Tan, J.L., McKinney, M.M., Lane, A.N. (2012) Stable isotope resolved metabolomics analysis of ribonucleotide and RNA metabolism in human lung cancer cells. Metabolomics, 8, 517-527.
93. Vazquez, A., Tedeschi, P.M., Bertino, J.R. (2013) Overexpression of the mitochondrial folate and glycine-serine pathway: a new determinant of methotrexate selectivity in tumors. Cancer Res., 73, 478-482.
94. Tedeschi, P.M., Markert, E.K., Gounder, M., Lin, H., Dvorzhinski, D., Dolfi, S.C., Chan, L.Y., Qiu, J., DiPaola, R.S., Hirshfield, K.M. et al. (2013) Contribution of serine, folate and glycine metabolism to the ATP, NADPH and purine requirements of cancer cells. Cell Death Dis., 4, e877.
95. Possemato, R., Marks, K.M., Shaul, Y.D., Pacold, M.E., Kim, D., Birsoy, K., Sethumadhavan, S., Woo, H.-K., Jang, H.G., Jha, A.K. et al. (2011) Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature, 476, 346-350.
96. Morrish, F., Isern, N., Sadilek, M., Jeffrey, M., Hockenbery, D.M. (2009) c-Myc activates multiple metabolic networks to generate substrates for cell-cycle entry. Oncogene, 28, 2485-2491.
97. Cory, J.G., Sato, A. (1983) Regulation of ribonucleotide reductase activity in mammalian cells. Mol. Cell. Biochem., 53, 257-266.
98. Frederiks, W.M., Vizan, P., Bosch, K.S., Vreeling-Sindelarova, H., Boren, J., Cascante, M. (2008) Elevated activity of the oxidative and non-oxidative pentose phosphate pathway in (pre)neoplastic lesions in rat liver. Int. J. Exp. Pathol., 89, 232-240.
99. Corey, J.G., Sato, A. (1983) Regulation of ribonucleotide reductase activity in mammalian cells. Mol. Cell. Biochem., 53, 257-266.
100. Ferraro, P., Franzolin, E., Pontarin, G., Reichard, P., Bianchi, V. (2009) Quantitation of cellular deoxynucleoside triphosphates. Nucleic Acids Res., 38, e85.
101. Yang, Y., Lane, A.N., Ricketts, C.J., Carole Sourbier, C., Wei, M.-H., Shuch, B., Pike, L., Wu, M., Rouault, T.A., Boros, L.G. et al. (2013) Metabolic reprogramming for producing energy and reducing power in fhydratase ncells from hereditary leiomyomatosis renal cell carcinoma. PLos One, 8, e72179.
102. Mullen, A.R., Wheaton, W.W., Jin, E.S., Chen, P.-H., Sullivan, L.B., Cheng, T., Yang, Y., Linehan, W.M., Chandel, N.S., DeBerardinis, R.J. (2011) Reductive carboxylation supports growth in tumour cells with defective mitochondria. Nature, 481, 385-388.
103. Wise, D.R., Ward, P.S., Shay, J.E.S., Cross, J.R., Gruber, J.J., Sachdev, U.M., Platt, J.M., DeMatteo, R.G., Simon, M.C., Thompson, C.B. (2011) Hypoxia promotes isocitrate dehydrogenasedependent carboxylation of-ketoglutarate to citrate to support cell growth and viability. PNAS, 108, 19611-19616.
104. Kamphorst, J.J., Cross, J.R., Fan, J., de Stanchina, E., Mathew, R., White, E.P., Thompson, C.B., Rabinowitz, J.D. (2013) Hypoxic and Ras-transformed cells support growth by scavenging unsaturated fatty acids from lysophospholipids. Proc. Natl. Acad. Sci. U.S.A., 110, 8882-8887.
105. DeBerardinis, R.J., Sayed, N., Ditsworth, D., Thompson, C.B. (2008) Brick by brick: metabolism and tumor cell growth. Curr. Opin. Genet. Dev., 18, 54-61.
106. Frezza, C., Zheng, L., Folger, O., Rajagopalan, K.N., MacKenzie, E.D., Jerby, L., Micaroni, M., Chaneton, B., Adam, J., Hedley, A. et al. (2011) Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase. Nature, 477, 225-228.
107. Tennant, D.A., Duran, R.V., Gottlieb, E. (2010) Targeting metabolic transformation for cancer therapy. Nat. Rev. Cancer, 10, 267-277.
108. Cardenas-Navia, L.I., Mace, D., Richardson, R.A., Wilson, D.F., Shan, S., Dewhirst, M.W. (2008) The pervasive presence of fluctuating oxygenation in tumors. Cancer Res., 68, 5812-5819.
109. Schroeder, T., Yuan, H., Viglianti, B.L., Peltz, C., Asopa, S., Vujaskovic, Z., Dewhirst, M.W. (2005) Spatial heterogeneity and oxygen dependence of glucose consumption in R3230Ac and fibrosarcomas of the Fischer 344 rat. Cancer Res., 65, 5163-5171.
110. Chandel, N.S., Budinger, G.R., Schumacker, P.T. (1996) Molecular oxygen modulates cytochrome c oxidase function. J. Biol. Chem., 271, 18672-18677.
111. Kraba, K., Kempe, H., Wikstr öm, M. (2011) Explaining the enigmatic KM for oxygen in cytochrome c oxidase: a kinetic model. Biochim. Biophys. Acta, 1807, 348-358.
112. Kim, J.W., Tchernyshyov, I., Semenza, G.L., Dang, C.V. (2006) HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab., 3, 177-185.
113. Semenza, G.L. (1999) Regulation of mammalian O-2 homeostasis by hypoxia-inducible factor 1. Annu. Rev. Cell Dev. Biol., 15, 551-578.
114. Myllyla, R., Tuderman, L., Kivirikko, K.I. (1977) Mechanism of the prolyl hydroxylase reaction. Eur. J. Biochem., 80, 349-357.
115. Jokilehto, T., Jaakkola, P.M. (2010) The role of HIF prolyl hydroxylases in tumour growth. J. Cell. Mol. Med., 14, 758-770.
116. Bos, R., van der Groep, P., Greijer, A.E., Shvarts, A., Meijer, S., Pinedo, H.M., Semenza, G.L., van Diest, P.J., van der Wall, E. (2003) Levels of hypoxia-inducible factor-1 alpha independently predict prognosis in patients with lymph node negative breast carcinoma. Cancer, 97, 1573-1581.
117. Strovas, T.J., McQuaide, S.C., Anderson, J.B., Nandakumar, V., Kalyuzhnaya, M.G., Burgess, L.W., Holl, M.R., Meldrum, D.R., Lidstrom, M.E. (2010) Direct measurement of oxygen consumption rates from attached and unattached cells in a reversibly sealed, diffusionally isolated sample chamber. Adv. Biosci. Biotechnol., 1, 398-408.
118. Telang, S., Lane, A.N., Nelson, K.K., Arumugam, S., Chesney, J.A. (2007) The oncoprotein H-RasV12 increases mitochondrial metabolism. Mol. Cancer, 6, 77.
119. Yang, Y., Lane, A.N., Fan, T.W.-M., Rickets, C., Wu, M., Boros, L., Linehan, W.M. (2013) Understanding how fumarate hydratase (FH) null cells use its central carbon for energy and malignant development. PLoS One, 8, e72179.
120. Wu, M., Neilson, A., Swift, A.L., Moran, R., Tamagnine, J., Parslow, D., Armistead, S., Lemire, K., Orrell, J., Teich, J. et al. (2007) Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells. Am. J. Physiol. Cell Physiol., 292, C125-C136.
121. Maŕn-Hernández, A., Gallardo-Pérez, J.C., Rodŕguez-Enŕquez, S., Encalada, R., Moreno-Sánchez, R., Saavedra, E. (2010) Modeling cancer glycolysis. Biochim. Biophys. Acta, 1807, 755-767.
122. Warburg, O. (1923) Versuche an überlebendem Carcinomgewebe (Methoden). Biochem. Zeitschr., 142, 317-333.
123. Guppy, M., Leedman, P., Zu, X., Russell, V. (2002) Contribution by different fuels and metabolic pathways to the total ATP turnover of proliferating MCF-7 breast cancer cells. Biochem. J., 364, 309-315.
124. Liu, W., Le, A., Lane, A.N., Fan, T.W.-M., Dang, C.V., Phang, J.M. (2012) The reprogramming of proline and glutamine metabolism contributes to the proliferative and metabolic responses to c-MYC. Proc. Natl. Acad. Sci. U.S.A., 109, 8983-8988.
125. DeBerardinis, R.J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., Thompson, C.B. (2007) Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc. Natl. Acad. Sci. U.S.A., 104, 19345-19350.
126. Brennan, L., Corless, M., Hewage, C., Malthouse, J.P.G., McClenaghan, N.H., Flatt, P.R., Newsholme, P. (2003) C-13 NMR analysis reveals a link between L-glutamine metabolism, D-glucose metabolism and gamma-glutamyl cycle activity in a clonal pancreatic beta-cell line. Diabetologia, 46, 1512-1521.
127. Newsholme, E.A., Crabtree, B., Ardawi, M.S.M. (1985) Glutamine metabolism in lymphocytes: its biochemical, physiological and clinical importance. Q. J. Exp. Physiol., 70, 473-489.
128. Gullino, P.M., Clark, S.H., Grantham, F.H. (1964) The interstial fluid of solid tumors. Cancer Res., 24, 780-797.
129. Fell, D. (1997) Understanding the Control of Metabolism. Portland Press, London.
130. Papin, J.A., Price, N.D., Wiback, S.J., Fell, D.A., Palsson, B.O. (2003) Metabolic pathways in the post-genome era. Trends Biochem. Sci., 28, 250-258.
131. Poulo, J.M., Elston, T., Lane, A.N., Macdonald, J.M., Cascante, M. (2012) Introduction to Metabolic Control Analysis. In: Fan, TW-M, Higashi, RM and Lane, AN (eds). Handbook of Metabolomics. Humana Press, NY.
132. Kohen, E., Kohen, C., Hirschberg, J.G., Wouters, A.W., Thorell, B., Westerhoff, H.V., Charyulu, K.K.N. (1983) Metabolic control and compartmentation in single living cells. Cell Biochem. Funct., 1, 3-16.
133. Thomas, S., Fell, D.A. (1998) The role of multiple enzyme activation in metabolic flux control. Adv. Enzyme Reg., 38, 65-85.
134. Kacser, H., Burns, J. (1973) The control of flux. Symp. Soc. Exp. Biol., 27, 65-104.
135. Marin-Hernandez, A., Rodriguez-Enriquez, S., Vital-Gonzalez, P.A., Flores-Rodriguez, F.L., Macias-Silva, M., Sosa-Garrocho, M., Moreno-Sanchez, R. (2006) Determining and understanding the control of glycolysis in fast-growth tumor cells-flux control by an over-expressed but strongly product-inhibited hexokinase. FEBS J., 273, 1975-1988.
136. Baumgartner, R., Walloschek, M., Kralik, M., Gotschlich, A., Tasler, S., Mies, J., Leban, J. (2006) Dual binding mode of a novel series of DHODH inhibitors. J. Med. Chem., 49, 1239-1247.
137. Abdelrahim, M., Samudio, I., Smith, R., Burghardt, R., Safe, S. (2002) Small inhibitory RNA duplexes for Sp1 mRNA block basal and estrogen-induced gene expression and cell cycle progression in MCF-7 breast cancer cells. J. Biol. Chem., 277, 28815-28822.
138. Sigoillot, F.D., Sigoillot, S.M., Guy, H.I. (2004) Breakdown of the regulatory control of pyrimidine biosynthesis in human breast cancer cells. Int. J. Cancer, 109, 491-498.
139. Graves, L.M., Guy, H.I., Kozlowski, P., Huang, M., Lazarowski, E., Pope, R.M., Collins, M.A., Dahlstrand, E.N., Earp, H.S., Evans, D.R. (2000) Regulation of carbamoyl phosphate synthetase by MAP kinase. Nature, 403, 328-332.
140. Gordan, J.D., Lal, P., Dondeti, V.R., Letrero, R., Parekh, K.N., Oquendo, C.E., Greenberg, R.A., Flaherty, K.T., Rathmell, W.K., Keith, B. et al. (2008) HIF-alpha effects on c-Myc distinguish two subtypes of sporadic VHL-deficient clear cell renal carcinoma. Cancer Cell, 14, 435-446.
141. Chen, K.F., Lai, Y.Y., Sun, H.S., Tsai, S.J. (2005) Transcriptional repression of human cad gene by hypoxia inducible factor-1 alpha. Nucleic Acids Res., 33, 5190-5198.
142. Gordan, J.D., Bertout, J.A., Hu, C.J., Diehl, J.A., Simon, M.C. (2007) HIF-2 alpha promotes hypoxic cell proliferation by enhancing c-Myc transcriptional activity. Cancer Cell, 11, 335-347.
143. Khan, S., Abdelrahim, M., Samudio, I., Safe, S. (2003) Estrogen receptor/Sp1 complexes are required for induction of cad gene expression by 17 beta-estradiol in breast cancer cells. Endocrinology, 144, 2325-2335.
144. Wyngaarden, J.B. (1976) Regulation of purine biosynthesis and turnover. Adv. Enzyme Regul., 14, 25-42.
145. Switzer, R.L., Sogin, D.C. (1973) Regulation and mechanism of phosphoribosylpyrophosphate synthetase V.Inhibition by end products and regulation by adenosine diphosphate. J. Biol. Chem., 248, 1063-1073.
146. Smith, J.L. (1998) Glutamine PRPP amidotransferase: snapshots of an enzyme in action. Curr. Opin. Struct. Biol., 8, 686-694.
147. Bera, A.K., Smith, J.L., Zalkin, H. (2000) Dual role for the glutamine phosphoribosylpyrophosphate amidotransferase ammonia channel. Interdomain signaling and intermediate channeling. J. Biol. Chem., 275, 7975-7979.
148. Holmes, E.W., Pehlke, D.M., Kelley, W.N. (1974) Human IMP dehydrogenase: kinetics and regulatory properties. Biochim. Biophys. Acta, 364, 209-217.
149. Hedstrom, L. (2009) IMP dehydrogenase: structure, mechanism and inhibition. Chem. Rev., 109, 2903-2928.
150. Van Der Weyden, M.B., Kelly, W.N. (1974) Human adenylosuccinate synthetase. Partial purification, kinetic and regulatory properties of the enzyme from placenta. J. Biol. Chem., 249, 7782-7289.
151. Anousis, N., Carvalho, R.A., Zhao, P.Y., Malloy, C.R., Sherry, A.D. (2004) Compartmentation of glycolysis and glycogenolysis in the perfused rat heart. NMR Biomed., 17, 51-59.
152. Easterby, J.S. (1989) The analysis of metabolite channelling in multienzyme complexes and multifunctional proteins. Biochem. J., 264, 605-607.
153. Lane, A.N., Kirschner, K. (1991) Mechanism of the physiological reaction catalyzed by tryptophan synthase from Escherichia-Coli. Biochemistry, 30, 479-484.
154. Rudolph, J., Stubbe, J. (1995) Investigation of the mechanism of phosphoribosylamine transfer from glutamine phosphoribosylpyrophosphate amidotransferase to glycinamide ribonucleotide synthetase. Biochemistry, 37, 2241-2250.
155. Zhao, A., Tsechansky, M., Ellington, A.D., Marcotte, E.M. (2014) Revisiting and revising the purinosome. Mol. Biosyst., 10, 369-374.
156. Al-Mehdi, A., Pastukh, V., Swiger, B., Reed, D., Patel, M., Bardwell, G., Pastukh, V., Alexeyev, M., Gillespie, M.N. (2012) Perinuclearmitochondrial clustering creates an oxidant-rich nuclear domain required for hypoxia-induced transcription. Sci. Signal, 5, ra47.
157. Nordlund, N., Reichard, P. (2006) Ribonucleotide reductases. Annu. Rev. Biochem., 75, 681-706.
158. Chimploy, K., Song, S.W., Wheeler, L.J., Mathews, C.K. (2013) Ribonucleotide reductase association with mammalian liver mitochondria. J. Biol. Chem., 288, 13145-13155.
159. Engstrom, Y., Eriksson, S., Jildevik, I., Skog, S., Thelander, L., Tribukait, B. (1985) Cell cycle-dependent expression of mammalian ribonucleotide reductase. J. Biol. Chem., 260, 9114-9116.
160. Guarino, E., Salguero, I., Kearsey, S.E. (2014) Cellular regulation of ribonucleotide reductase in eukaryotes. Semin. Cell Dev. Biol., 30, 97-103.
161. Lin, Z.P., Lee, Y., Lin, F., Belcourt, M.F., Li, P.N., Cory, J.G., Glazer, P.M., Sartorelli, A.C. (2011) Reduced level of ribonucleotide reductase R2 subunits increases dependence on homologous recombination repair of cisplatin-induced DNA damage. Mol. Pharmacol., 80, 1000-1012.
162. Tanaka, H., Arakawa, H., Yamaguchi, T., Shiraishi, K., Fukuda, S., Matsui, K., Takei, Y., Nakamura, Y. (2000) A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage. Nature, 404, 42-49.
163. Nakano, K., Balint, E., Ashcroft, M., Vousden, K.H. (2000) A ribonucleotide reductase gene is a transcriptional target of p53 and p73. Oncogene, 19, 4283-4289.
164. Nordlund, P., Reichard, P. (2006) Ribonucleotide reductases. Annu. Rev. Biochem., 75, 681-706.
165. Rennie, M. (1999) An introduction to the use of tracers in nutrition and metabolism. Proc. Nutr. Soc., 58, 935-944.
166. Fan, J., Ye, J.B., Kamphorst, J.J., Shlomi, T., Thompson, C.B., Rabinowitz, J.D. (2014) Quantitative flux analysis reveals folate-dependent NADPH production. Nature, 510, 298-302.
167. Lane, A.N., Fan, T.W., Higashi, R.M. (2008) Isotopomer-based metabolomic analysis by NMR and mass spectrometry. Methods Cell Biol., 84, 541-588.
168. Lorkiewicz, P.K., Higashi, R.M., Lane, A.N., Fan, T.W.-M. (2012) High information throughput analysis of nucleotides and their isotopically enriched isotopologues by direct-infusion FTICR-MS. Metabolomics, 8, 930-939.
169. Lane, A.N. (2012) Introduction to Metabolomics. In: Fan, TW-M, Lane, AN and Higashi, RM (eds). Handbook of Metabolomics. Humana, NY.
170. Higashi, R.M., Fan, T.W.-M., Lorkiewicz, P.K., Moseley, H.N.B., Lane, A.N. (2014) Stable isotope-labeled tracers for metabolic pathway elucidation by GC-MS and FT-MS. Methods Mol. Biol., 1198, 147-167.
171. Neese, R.A., Siler, S.Q., Cesar, D., Antelo, F., Lee, D., Misell, L., Patel, K., Tehrani, S., Shah, P., Hellerstein, M.K. (2001) Advances in the stable isotope-mass spectrometric measurement of DNA synthesis and cell proliferation. Anal. Biochem., 298, 189-195.
172. Robinson, M.M., Turner, S.M., Hellerstein, M.K., Hamilton, K.L., Miller, B.F. (2011) Long-term synthesis rates of skeletal muscle DNA and protein are higher during aerobic training in older humans than in sedentary young subjects but are not altered by protein supplementation. FASEB J., 25, 3240-3249.
173. Moseley, H.N.B., Lane, A.N., Belshoff, A.C., Higashi, R.M., Fan, T.W.-M. (2011) Non-steady state modeling of UDP-GlcNAc biosynthesis is enabled by stable isotope resolved metabolomics (SIRM). BMC Biol., 9, 37.
174. Lane, A.N., Fan, T.W.-M., Bousamra, II, Higashi, R.M., Yan, J., Miller, D.M. (2011) Clinical applications of stable isotope-resolved metabolomics (SIRM) in non-small cell lung cancer. Omics, 15, 173-182.
175. Fan, T.W., Lane, A.N., Higashi, R.M., Farag, M.A., Gao, H., Bousamra, M., Miller, D.M. (2009) Altered regulation of metabolic pathways in human lung cancer discerned by 13C stable isotope-resolved metabolomics (SIRM). Mol. Cancer, 8, 41.
176. Fan, T.W.-M., Lane, A.N., Higashi, R.M., Yan, J. (2011) Stable isotope resolved metabolomics of lung cancer in a SCID mouse model. Metabolomics, 7, 257-269.
177. Fan, T.W.-M., Lane, A.N. (2011) NMR-based stable isotope resolved metabolomics in systems biochemistry. J. Biomol. NMR, 49, 267-280.
178. Lane, A.N., Fan, T.W. (2007) Quantification and identification of isotopomer distributions of metabolites in crude cell extracts using 1H TOCSY. Metabolomics, 3, 79-86.
179. Fan, T.W.-M., Kucia, M., Jankowski, K., Higashi, R.M., Rataczjak, M.Z., Rataczjak, J., Lane, A.N. (2008) Proliferating rhabdomyosarcoma cells shows an energy producing anabolic metabolic phenotype compared with Primary Myocytes. Mol. Cancer, 7, 79.
180. Moseley, H.N.B., Higashi, R.M., Fan, T.W.-M., Lane, A.N. (2011) Proceedings of Bioinformatics 2011. SciTePress, Rome. pp. 108-115.
181. Arese, P., Turrini, F., Schwarzer, E. (2005) Band 3/complement-mediated recognition and removal of normally senescent and pathological human erythrocytes. Cell Physiol. Biochem., 16, 133-146.
182. Ramos-Montoya, A., Lee, W.N.P., Bassilian, S., Lim, S., Trebukhina, R.V., Kazhyna, M.V., Ciudad, C.J., Noe, V., Centelles, J.J., Cascante, M. (2006) Pentose phosphate cycle oxidative and nonoxidative balance: a new vulnerable target for overcoming drug resistance in cancer. Int. J. Cancer, 119, 2733-2741.
183. Lee, W.-N.P., Boros, L.G., Puigjaner, J., Bassilian, S., Lim, S., Cascante, M. (1998) Mass isotopomer study of the nonoxidative pathways of the pentose cycle with [1, 2-13C2]glucose. Am. J. Physiol. Endocrinol. Metab., 274, E843-E851.
184. Marin, S., Lee, W.N.P., Bassilian, S., Lim, S., Boros, L.G., Centelles, J.J., Fernandez-Novell, J.M., Guinovart, J.J., Cascante, M. (2004) Dynamic profiling of the glucose metabolic network in fasted rat hepatocytes using 1, 2-C-13(2) glucose. Biochem. J., 381, 287-294.
185. Centelles, J.J., Ramos-Montoya, A., Lim, S., Bassilian, S., Boros, L.G., Marin, S., Cascante, M., Lee, W.N.P. (2007) Metabolic profile and quantification of deoxyribose synthesis pathways in HepG2 cells. Metabolomics, 3, 105-111.
186. Kominsky, D.J., Klawitter, J., Brown, J.L., Boros, L.G., Melo, J.V., Eckhardt, S.G., Serkova, N.J. (2009) Abnormalities in glucose uptake and metabolism in imatinib-resistant human BCR-ABL-positive cells. Clin. Cancer Res., 15, 3442-3450.
187. Kleijn, R.J., van Winden, W.A., van Gulik, W.M., Heijnen, J.J. (2005) Revisiting the 13C-label distribution of the non-oxidative branch of the pentose phosphate pathway based upon kinetic and genetic evidence. FEBS J., 272, 4970-4982.
188. Miccheli, A., Tomassini, A., Puccetti, C., Valerio, M., Peluso, G., Tuccillo, F., Calvani, M., Manetti, C., Conti, F. (2006) Metabolic profiling by C-13-NMR spectroscopy: [1, 2-C-13(2)] glucose reveals a heterogeneous metabolism in human leukemia T cells. Biochimie, 88, 437-448.
189. Boros, L.G., Puigjaner, J., Cascante, M., Lee, W.N.P., Brandes, J.L., Bassilian, S., Yusuf, F.I., Williams, R.D., Muscarella, P., Melvin, W.S. et al. (1997) Oxythiamine and dehydroepiandrosterone inhibit the nonoxidative synthesis of ribose and tumor cell proliferation. Cancer Res., 57, 4242-4248.
190. Boros, L.G., Lee, W.P., Muscarella, P., Fisher, W.E., Schirmer, W.J., Melvin, W.S. (1997) Inhibitors of the oxidative and non-oxidative pentose phosphate pathways inhibit pancreatic cancer cell proliferation. Gastroenterology, 112, A540.
191. Vizan, P., Boros, L.G., Figueras, A., Capella, G., Mangues, R., Bassilian, S., Lim, S., Lee, W.-N.P., Cascante, M. (2005) K-ras codon-specific mutations produce distinctive metabolic phenotypes in human fibroblasts. Cancer Res., 65, 5512-5515.
192. Ying, H., Kimmelman, A.C., Lyssiotis, A.C., Hua, S., Chu, G.C., Fletcher-Sananikone, E., Locasale, J.W., Son, J., Zhang, H., Coloff, J.L. et al. (2012) Oncogenic kras maintains pancreatic tumors through regulation of anabolic glucose metabolism. Cell, 149, 656-670.
193. Delgado, T.C., Castro, M.M., Geraldes, C.F., Jones, J.G. (2004) Quantitation of erythrocyte pentose pathway flux with [2-(13)]Glucose and H-1 NMR analysis of the lactate methyl signal. Magn. Reson. Med., 51, 1283-1286.
194. Marin-Valencia, I., Yang, C.D., Mashimo, T., Cho, S., Baek, H., Yang, X.L., Rajagopalan, K.N., Maddie, M., Vemireddy, V., Zhao, Z.Z. et al. (2012) Analysis of tumor metabolism reveals mitochondrial glucose oxidation in genetically diverse human glioblastomas in the mouse brain in vivo. Cell Metab., 15, 827-837.
195. Wishart, D.S.E.A. (2013) HMDB 3.0-The Human Metabolome Database in 2013. Nucleic Acids Res., 41, D801-D807.
196. Broer, S. (2008) Amino acid transport across mammalian intestinal and renal epithelia. Phyiol. Rev., 88, 249-286.
197. Sellers, K., Fox, M.P., Bousamra, M., Slone, S., Higashi, R.M., Miller, D.M., Wang, Y., Yan, J., Yuneva, M.O., Deshpande, R. et al. (2014) Pyruvate carboxylase is critical in non-small cell lung cancer. J. Clin. Invest., doi:10.1172/JCI72873.
198. Maher, E.A., Marin-Valencia, I., Bachoo, R.M., Mashimo, T., Raisanen, J., Hatanpaa, K.J., Jindal, A., Jeffrey, F.M., Choi, C.H., Madden, C. et al. (2012) Metabolism of U-13C glucose in human brain tumors in vivo. NMR Biomed., 25, 1234-1244.
199. Son, J., Lyssiotis, C.A., Ying, H., Wang, X., Hua, S., Ligorio, M., Perera, R.M., Ferrone, C.R., Mullarky, E., Ng, S.-C. et al. (2013) Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway. Nature, 496, 101.
200. Yang, C., Sudderth, J., Dang, T., Bachoo, R.G., McDonald, J.G., DeBerardinis, R.J. (2009) Glioblastoma cells require glutamate dehydrogenase to survive impairments of glucose metabolism or akt signaling. Cancer Res., 69, 7986-7993.
201. Wise, D.R., DeBerardinis, R.J., Mancuso, A., Sayed, N., Zhang, X.-Y., Pfeiffer, H.K., Nissim, I., Daikhin, E., Yudkoff, M., McMahon, S.B. et al. (2008) Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proc. Natl. Acad. Sci. U.S.A., 105, 18782-18787.
202. Mazurek, S., Eigenbrodt, E., Failing, K., Steinberg, P. (1999) Alterations in the glycolytic and glutaminolytic pathways after malignant transformation of rat liver oval cells. J. Cell. Physiol., 181, 136-146.
203. Kelly, A., Li, C.H., Gao, Z.Y., Stanley, C.A., Matschinsky, F.M. (2002) Glutantinolysis and insulin secretion-from bedside to bench and back. Diabetes, 51, S421-S426.
204. McKeehan, W.L. (1982) Glycolysis, glutaminolysis and cell proliferation. Cell Biol. Int. Rep., 6, 635-650.
205. Cheng, T., Sudderth, J., Yang, C., Mullen, A.R., Jin, E.S., Mates, J.M., DeBerardinis, R.J. (2011) Pyruvate carboxylase is required for glutamine-independent growth of tumor cells. Proc. Natl. Acad. Sci. U.S.A., 108, 8674-8679.
206. Donadio, A.C., Lobo, C., Tosina, M., Rosa, V., Martin-Rufian, M., Campos-Sandoval, J.A., Mates, J.M., Marquez, J., Alonso, F.J., Segura, J.A. (2008) Antisense glutaminase inhibition modifies the O-GlcNAc pattern and flux through the hexosamine pathway in breast cancer cells. J. Cell. Biochem., 103, 800-811.
207. Mates, J.M., Segura, J.A., Alonso, F.J., Marquez, J. (2006) Pathways from glutamine to apoptosis. Front. Biosci., 11, 3164-3180.
208. Thornburg, J.M., Nelson, K.K., Lane, A.N., Arumugam, S., Simmons, A., Eaton, J.W., Telang, S., Chesney, J. (2008) Targeting aspartate aminotransferase in breast cancer. Breast Cancer Res., 10, R84.
209. Wang, J., Alexander, P., Wu, L., Hammer, R., Cleaver, O., McKnight, S. (2009) Dependence of mouse embryonic stem cells on threonine catabolism. Science, 325, 435-439.
210. Wishart, D.S., Jewison, T., Guo, A.C., Wilson, M., Knox, C., Liu, Y.F., Djoumbou, Y., Mandal, R., Aziat, F., Dong, E. et al. (2013) HMDB 3.0-The Human Metabolome Database in 2013. Nucleic Acids Res., 41, D801-D807.
211. Wang, W.W., Wu, Z.L., Dai, Z.L., Yang, Y., Wang, J.J., Wu, G.Y. (2013) Glycine metabolism in animals and humans: implications for nutrition and health. Amino Acids, 45, 463-477.
212. Edgar, A.J. (2005) Mice have a transcribed L-threonine aldolase/GLY1 gene, but the human GLY1 gene is a non-processed pseudogene. BMC Genomics, 6, 32-44.
213. Lewis, C.A., Parker, S.J., Fiske, B.P., McCloskey, D., Gui, D.Y., Green, C.R., Vokes, N.I., Feist, A.M., Vander Heiden, M.G., Metallo, C.M. (2014) Tracing compartmentalized NADPH metabolism in the cytosol and mitochondria of mammalian cells. Mol. Cell, 55, 253-263.
214. Murphy, T.A., Dang, C.V., Young, J.D. (2013) Isotopically nonstationary 13C flux analysis of Myc-induced metabolic reprogramming in B-cells. Metab. Eng., 15, 206-217.
215. Dolfi, S.C., Chan, L.L.-Y., Qiu, J., Tedeschi, P.M., Bertino, J.R., Hirshfield, K.M., Oltvai, Z.N., Vazquez, A. (2013) The metabolic demands of cancer cells are coupled to their size and protein synthesis rates. Cancer Metab., 1, 20.
216. Labuschagne, C., van den Broek, N., Mackay, G., Vousden, K., Maddocks, O.D. (2014) Serine, but not glycine, supports one-carbon metabolism and proliferation of cancer cells. Cell Rep., 7, 1248-1258.
217. Guin, S., Pollard, C., Ru, Y.B., Lew, C.R., Duex, J.E., Dancik, G., Owens, C., Spencer, A., Knight, S., Holemon, H. et al. (2014) Role in tumor growth of a glycogen debranching enzyme lost in glycogen storage disease. J. Natl. Cancer Inst., 106, dju062.
218. Pérignon, J.L., Bories, D.M., Houllier, A.M., Thuillier, L., Cartier, P.H. (1987) Metabolism of pyrimidine bases and nucleosides by pyrimidine-nucleoside phosphorylases in cultured human lymphoid cells. Biochim. Biophys. Acta, 928, 130-136.
219. Navaratnam, N., Sarwar, R. (2006) An overview of cytidine deaminases. Int. J. Hematol., 83, 195-200.
220. Suzuki, N.N., Koizumi, K., Fukushima, M., Matsuda, A., Inagaki, F. (2004) Structural basis for the specificity, catalysis, and regulation of human uridine-cytidine kinase. Structure, 12, 751-764.
221. Qi, Z., Voit, E.O. (2014) Identification of cancer mechanisms through computational systems modeling. Transl. Cancer Res., 3, 233-242.
222. Meyer, J.S., Cosatto, E., Graf, H.P. (2009) Mitotic index of invasive breast carcinoma. Arch. Pathol. Lab.Med., 133, 1826-1833.
223. Sellers, K., Fox, M.P., Bousamra, M., Slone, S., Higashi, R.M., Miller, D.M., Wang, Y., Yan, J., Yuneva, M.O., Deshpande, R. et al. (2014) Pyruvate carboxylase is upregulated in NSCLC. J. Clin. Invest., in press.
224. Fan, T.W. (2012) Considerations of Sample Preparation for Metabolomics Investigation. In: Fan, TW, Lane, AN and Hiagshi, RM (eds). Handbook of Metabolomics. Vol. 17 . Humana, New York.
225. Hellerstein, M.K., Neese, R.A. (1999) Mass isotopomer distribution analysis at eight years: theoretical, analytic, and experimental considerations. Am. J. Physiol., 276, E1146-E1170.
226. Bousamra, M., Day, J., Fan, T.W.-M., Higashi, R.M., Kloecker, G., Lane, A.N., Miller, D.M. (2012) The Handbook of Metabolomics. Humana, Totoya, Vol. 17.
227. Lane, A.N., Fan, T.W., Higashi, R.M., Tan, J., Bousamra, M., Miller, D.M. (2009) Prospects for clinical cancer metabolomics using stable isotope tracers. J. Exp. Molec. Pathol., 86, 165-173.
228. Christopherson, R.I., Lyons, S.D., Wilson, P.K. (2002) Inhibitors of de novo nucleotide biosynthesis as drugs. Acc. Chem. Res., 35, 961-971.
229. Teschner, S., Burst, V. (2010) Leflunomide: a drug with a potential beyond rheumatology. Immunotherapy, 2, 637-650.